FINCH THERAPEUTICS GROUP INC (FNCH) Stock Analyst Earnings Estimates
NASDAQ:FNCH - Nasdaq - US31773D2009 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 18.53M 140.03% | 860K -95.36% | 107K -87.56% | -100.00% | 90.27M | 352.31M 290.28% | 699.31M 98.49% | 843.95M 20.68% | 959.82M 13.73% | 1.099B 14.50% | |
| EBITDA YoY % growth | -57.69M -49.26% | -89.61M -55.33% | -32.482M 63.75% | -52.326M -61.09% | N/A | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -59.99M -52.10% | -95.12M -58.56% | -34.002M 64.25% | -33.66M 1.01% | N/A | N/A | N/A | N/A | N/A | N/A | |
| Operating Margin | -323.75% | -11,060.47% | -31,777.57% | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EPS YoY % growth | -13.53 | N/A -360.24% | N/A 37.59% | -21.00 45.96% | N/A | N/A | N/A | N/A | N/A | N/A |
All data in USD
| EPS Q2Q % growth |
|---|
| Revenue Q2Q % growth |
| EBITDA Q2Q % growth |
| EBIT Q2Q % growth |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2023 Q2Q % growth | -3.24 77.50% | -4.59 | 1.35 | 29.41% |
| Q1 2023 Q2Q % growth | -11.40 | -2.75 | -8.65 | -313.94% |
| Q4 2022 Q2Q % growth | -16.80 -40.00% | -10.40 | -6.40 | -61.48% |
| Q3 2022 Q2Q % growth | -25.50 -12,042.86% | -12.24 | -13.26 | -108.33% |
| Q2 2022 Q2Q % growth | -14.40 -4,400.00% | -12.70 | -1.70 | -13.39% |
| Q4 2021 Q2Q % growth | -12.00 | -9.79 | -2.21 | -22.55% |
| Q3 2021 Q2Q % growth | -0.21 | -0.43 | 0.22 | 50.98% |
| Q2 2021 Q2Q % growth | -0.32 | -0.29 | -0.03 | -12.04% |
| Q1 2021 Q2Q % growth | -1.00 | -0.24 | -0.76 | -308.50% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2023 Q2Q % growth | -100.00% | % | ||
| Q1 2023 Q2Q % growth | 107K -69.43% | 107K | % | |
| Q4 2022 Q2Q % growth | 10K -98.77% | 408K | -398K | -97.55% |
| Q3 2022 Q2Q % growth | 140K -98.77% | 765K | -625K | -81.70% |
| Q2 2022 Q2Q % growth | 360K -87.28% | 663K | -303K | -45.70% |
| Q1 2022 Q2Q % growth | 350K -90.14% | % | ||
| Q4 2021 Q2Q % growth | 810K -55.25% | 5.1M | -4.29M | -84.12% |
| Q3 2021 Q2Q % growth | 11.34M 540.68% | 11.34M | % | |
| Q2 2021 Q2Q % growth | 2.83M 20.43% | 2.83M | % | |
| Q1 2021 Q2Q % growth | 3.55M 98.32% | 3.55M | % |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | N/A | N/A | 0% | 0% |
| Revenue | N/A | N/A | N/A | N/A |